Histopathological and Genomic Grading Provide Complementary Prognostic Information in Breast Cancer: A Study on Publicly Available Datasets

Table 1

Clinicopathological features of all breast cancer patients analyzed in the study.

Age
≤40 years	97
41–55 years	381
56–70 years	397
>70 years	205
Missing	9
Size
<2 cm	520
>2 cm	560
Missing	9
Node
Positive	799
Negative	263
Missing	27
ER
Positive	896
Negative	180
Missing	13
Histopathological grade
Grade 1	168
Grade 2	404
Grade 3	356
Missing	161
Genomic grade
Low	501
High	488
Missing	100
Adjuvant treatment
None	655
Tamoxifen	425
Missing	9